Skip to main content
. 2022 Jul 22;12:948293. doi: 10.3389/fonc.2022.948293

Figure 2.

Figure 2

Representative images of gastrointestinal bleeding and exacerbation of varicose veins after atezolizumab plus bevacizumab treatment. (A) Patients that developed gastrointestinal bleeding after treatment with atezolizumab plus bevacizumab. (B) Patients in which varices exacerbated during atezolizumab plus bevacizumab treatment. AB, atezolizumab plus bevacizumab treatment.